The future of digital health part 2: Digital patient engagement and virtual healthcare delivery

Part 2

Last week, we started a new series featuring healthcare visionary and thought leader Andy Dé. In this series, Dé discusses how COVID-19 has triggered remarkable digital transformation and uncovers five long-term innovation implications that providers, healthcare leaders, and payers need to consider.

Catch up on the first implication—advanced analytics for vaccine administration—then read on to explore number two in this week’s article.


Innovation implication #2: Digital patient engagement and virtual healthcare delivery

Protecting the health, well-being and safety of healthcare practitioners and first responders is paramount — and will accelerate adoption of Digital Patient Engagement (DPE), enabled by Virtual Healthcare Delivery (VHD) solutions (also known as “Hospital at Home.)”

As pictured below, there are three primary drivers for DPE and VHD:

  1. A clear need to deliver high quality healthcare to a massive number of patients afflicted with a contagious disease and co-morbidities.
  2. Risks presented by acquiring COVID-19 combined with continued lack of sufficient equipment, PPE, and rest for healthcare workers
  3. The need to minimize direct contact of providers with patients while increasing level of care efficiency and productivity

When I have this conversation with healthcare colleagues, the next question I typically receive is: “Andy, this sounds great, but where do we start?” The chart below demonstrates several helpful examples of how technology can be used to transform typical patient interactions and needs:

If you’re interested in more details about how to actually make changes like the ones described above, reach out to start a conversation. Join me back here on the MedeAnalytics blog next week for Innovation implications #3: Artificial intelligence and machine learning for operations, revenue cycle and supply change management innovation and #4: Medical robotics.

Andy Dé

Andy Dé is the Chief Marketing Officer. Andy joined MedeAnalytics in March 2021 bringing more than 20 years of enterprise software product marketing, product management and industry strategy experience. In his role, Andy oversees the company’s go-to-market (GTM) strategy and marketing. He is passionate about healthcare innovation and is recognized as an industry thought leader in healthcare.

Get our take on industry trends

COVID-19 and the Financial Storm Ahead for Providers

May 14, 2020

Across the country, healthcare organizations are seeing 40%-80% declines in monthly charges with some of the most profitable services lines only seeing 20% of their normal monthly volumes during the pandemic.

Read on...

3 Steps Any Healthcare Organization Can Take to Improve Enterprise Analytics

February 24, 2020

By Kristin Weir When it comes down to the most basic purpose of why organizations use analytics, it’s simple: they…

Read on...

Why Predictive Analytics is the Answer to Healthcare’s Big Data Problem

February 7, 2020

By Scott Hampel Making improvements in healthcare data analytics has the potential to lead to significant cost savings and improved…

Read on...

Unfamiliar Healthcare Players, Interoperability and Social Determinants Round Out 2020 Megatrends

January 23, 2020

By Scott Hampel, president of MedeAnaltyics We conclude our 2020 Megatrends with an exploration of new players entering healthcare, the…

Read on...